New COVID-19 treatment rules: India cuts down use of Remdesivir, Tocilizumab, multivitamins, steroids
According to the new guidelines, Remdesivir may be considered only in patients who have completed 10 days since the start of the symptoms and require supplemental oxygen.
The analysis included information on 10,930 patients, of whom 6,449 were randomly assigned to receive interleukin-6 inhibitors and 4,481 to receive usual care or placebo.
DGHS issues COVID-19 treatment guidelines: Here is what document recommends on Remdesivir, Tocilizumab
Among the drugs and treatment methods that have been removed from the recommendations are Ivermectin, Azithromycin and plasma therapy
States must form special teams to 'mercilessly' clamp down on black market of COVID-19 drugs: Centre to SC
In an affidavit, the Centre said the DCGI has communicated to all state drugs controllers to take strict action against hoarding and black marketing of drugs like remdesivir
COVID-19 cases surge: Centre flags gaps in containment measures of three states, bans Remdesivir exports
Speaking after an all-party meeting held virtually to discuss the COVID-19 situation in Maharashtra on Sunday, state health minister Rajesh Tope said an appropriate decision regarding imposing a lockdown in Maharashtra will be taken after 14 April
Drugs inspectors and other officers have been directed to verify stocks, check malpractices and also take other effective actions to curb hoarding and black marketing, the Union Health Ministry said
Arthritis drug Tocilizumab may improve survival in patients with severe COVID-19, Indian study proposes
Another large study in the UK has found tocilizumab effective in preventing death in COVID-19 patients who suffered from hypoxia and systemic inflammation.
Timely treatment with tocilizumab likely to improve clinical outcomes in severe COVID-19 patients, finds study
The drug is already approved and is used for the treatment of rheumatoid arthritis, an autoimmune disease that leads to joint inflammation and pain
A 14-year-old girl was admitted to a Mumbai hospital with rashes and high fever, classic symptoms of Kawasaki syndrome.
Maharashtra makes Aadhaar card, positive test, doctor's prescription mandatory to buy COVID-19 drugs
The anti-viral drug remdesivir was cleared for 'restricted emergency use' to treat severe COVID-19 patients last month, causing a spike in demand for the medicine
Centre includes includes dexamethasone drug in COVID-19 treatment protocol for moderate to severe cases
The updated protocol includes the advice to use dexamethasone as an alternative choice to methylprednisolone for managing moderate to severe cases of COVID-19.
COVID-19 treatment: Fabiflu by Glenmark, HCQ, Remdesivir and other drugs that are being used to treat coronavirus patients
Favipiravir is an antiviral drug which was developed by a Japanese pharma company, Fujifilm Toyama Chemical, to treat influenza.
Treating COVID-19: As widely-available steroid dexamethasone raises hopes, a look at other potential treatments in trials already
So far there are no approved treatments for the coronavirus infection which has claimed more than 443,000 lives globally and 9,900 in India alone
COVID-19 'RECOVERY' Trial: Dexamethasone found life-saving in seriously-ill patients in preliminary tests
As part of the Recovery trial, a range of potential treatments is being tested in consenting COVID-19 patients admitted to NHS hospitals in the UK.
Health ministry recommends tocilizumab, HCQ, plasma therapy for patients in the moderate stage of COVID-19
HCQ has demonstrated in-vitro activity against SARS-CoV-2 and shown to be clinically beneficial in several small single-centre studies with significant limitations.
Health ministry allows use of HCQ in early stages of COVID-19, Remdesivir in moderate patients as infections climb over 3.2 lakh
The government came out with a revised treatment protocol to deal with COVID-19, allowing use of antiviral drug Remdesivir in moderate cases and hydroxychloroquine in patients during the early course of the disease
The FDA-approved treatment is available to patients of certain types of cancer and their insurance coverage.
Targeted suppression of inflammation in the body can improve cognitive problems of patients with schizophrenia, according to US researchers.